Afinitor
Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.
What Afinitor means in everyday medical language
Afinitor is a medicine that contains the drug everolimus. It is used to treat certain cancers and some non-cancerous tumors. Afinitor works by slowing down the growth of abnormal cells and the blood vessels that tumors need to grow. This helps control the disease and may improve symptoms or slow its progression. It is a type of targeted therapy, meaning it focuses on specific parts of cancer cells rather than affecting many cells like traditional chemotherapy.
Why Afinitor matters in cancer care
Afinitor is important because it offers a treatment option for cancers that may not respond well to other therapies. It is approved for some breast cancers, kidney cancers, and neuroendocrine tumors, which are tumors that can develop in organs like the pancreas, lungs, or digestive system. It also treats certain benign tumors linked to a genetic condition called tuberous sclerosis, which causes growths in the brain and kidneys. By blocking a protein called mTOR, Afinitor slows cell growth and the formation of new blood vessels that tumors need to survive.
What patients might see or hear about Afinitor
Patients may come across the name Afinitor in their medical records, treatment plans, or during discussions with their healthcare team. It might also appear in information about clinical trials or drug guides. Seeing Afinitor listed does not always mean it will be part of a patient’s treatment, but it signals that this drug is a possible option depending on the diagnosis and other factors. Doctors may mention Afinitor when planning treatment or monitoring how well therapy is working.
How Afinitor fits into treatment and related terms
Afinitor is often used alone or combined with other medicines depending on the type and stage of cancer. It belongs to a group of drugs called kinase inhibitors and angiogenesis inhibitors, which target specific proteins involved in cancer growth and blood vessel formation. The active drug inside Afinitor is everolimus, so these names are sometimes used interchangeably. Afinitor Disperz is a related form used mainly for certain non-cancerous brain tumors and seizures linked to tuberous sclerosis.
Common questions to ask your care team
If Afinitor is mentioned as a treatment option, helpful questions include: How does Afinitor work for my specific cancer or tumor? What side effects should I expect, and how can they be managed? Will Afinitor be used alone or with other medicines? How will we know if the treatment is working? Are there any lifestyle changes I should make while taking Afinitor? Asking these questions can help you understand your care and feel more confident about your treatment plan.
Understanding Afinitor in context and safety information
It is important to know that hearing about Afinitor does not automatically mean a patient’s cancer will be treated with this drug. Its use depends on specific cancer types, disease stage, and how the patient responds to other treatments. Afinitor is not a cure but a way to help control tumor growth and improve quality of life. Side effects and benefits vary among patients, so doctors carefully decide when it is appropriate to use. Always talk with your healthcare provider about your specific condition and treatment options. Never start, stop, or change medication without professional guidance.
Next steps for patients and caregivers
If you want to learn more about Afinitor, the best step is to discuss it with your oncology team. They can explain whether Afinitor is suitable for your cancer or tumor and how it might be combined with other treatments. You can also ask for written information or trusted resources to read at home. Understanding your treatment options helps you take an active role in your care and make informed decisions alongside your doctors and caregivers.
Sources
Public source information used for this glossary entry includes: